BACKGROUND: Prediction of mortality may improve management and outcomes of patients with sepsis in resource-limited settings. Therefore, we evaluated the ability of a hand-held portable whole-blood lactate (PWBL) analyzer to predict mortality of patients who are admitted to the hospital with severe sepsis. METHODS: A prospective observational study enrolled 253 patients at a national referral hospital in Uganda. Inclusion criteria required (1) >or=2 systemic inflammatory response syndrome criteria or thermodysregulation, (2) hypotension, and (3) suspected infection. A subset of 72 patients had PWBL and standard laboratory serum lactate measured. The primary measured outcome was in-hospital mortality. RESULTS: Fifty-nine (81.9%) of 72 evaluated patients were infected with human immunodeficiency virus type 1. The in-hospital mortality rate was 25.7% (18 of 70), and the in- and outpatient mortality at 30 days was 41.6% (30 of 72). PWBL was positively associated with in-hospital but not outpatient mortality (P=.001). The receiver operating characteristic area under the curve for PWBL was 0.81 (P=.081). The optimal PWBL concentration for predicting in-hospital mortality (sensitivity, 88.3%; specificity, 71.2%) was >or=4.0 mmol/L. Patients with a PWBL concentration >or=4.0 mmol/L died while in the hospital substantially more often (50.0%) than did those with a PWBL concentration <4.0 mmol/L (7.5%) (odds ratio, 12.3; 95% confidence interval, 3.5-48.9; [P=.001). Standard laboratory serum lactate results were inconsistent and less predictive of mortality than were those of PWBL in a multiple logistic regression model. CONCLUSION: A PWBL concentration >or=4.0 mmol/L predicts with 81% accuracy a 7-fold higher mortality of patients with sepsis than does a PWBL concentration <4.0 mmol/L. PWBL testing would be useful in places where clinical decisions are limited by lack of laboratory infrastructure and poor reliability.
BACKGROUND: Prediction of mortality may improve management and outcomes of patients with sepsis in resource-limited settings. Therefore, we evaluated the ability of a hand-held portable whole-blood lactate (PWBL) analyzer to predict mortality of patients who are admitted to the hospital with severe sepsis. METHODS: A prospective observational study enrolled 253 patients at a national referral hospital in Uganda. Inclusion criteria required (1) >or=2 systemic inflammatory response syndrome criteria or thermodysregulation, (2) hypotension, and (3) suspected infection. A subset of 72 patients had PWBL and standard laboratory serum lactate measured. The primary measured outcome was in-hospital mortality. RESULTS: Fifty-nine (81.9%) of 72 evaluated patients were infected with human immunodeficiency virus type 1. The in-hospital mortality rate was 25.7% (18 of 70), and the in- and outpatient mortality at 30 days was 41.6% (30 of 72). PWBL was positively associated with in-hospital but not outpatient mortality (P=.001). The receiver operating characteristic area under the curve for PWBL was 0.81 (P=.081). The optimal PWBL concentration for predicting in-hospital mortality (sensitivity, 88.3%; specificity, 71.2%) was >or=4.0 mmol/L. Patients with a PWBL concentration >or=4.0 mmol/L died while in the hospital substantially more often (50.0%) than did those with a PWBL concentration <4.0 mmol/L (7.5%) (odds ratio, 12.3; 95% confidence interval, 3.5-48.9; [P=.001). Standard laboratory serum lactate results were inconsistent and less predictive of mortality than were those of PWBL in a multiple logistic regression model. CONCLUSION: A PWBL concentration >or=4.0 mmol/L predicts with 81% accuracy a 7-fold higher mortality of patients with sepsis than does a PWBL concentration <4.0 mmol/L. PWBL testing would be useful in places where clinical decisions are limited by lack of laboratory infrastructure and poor reliability.
Authors: Richard Ssekitoleko; Relana Pinkerton; Rose Muhindo; Sanjay Bhagani; Christopher C Moore Journal: Am J Trop Med Hyg Date: 2011-10 Impact factor: 2.345
Authors: Richard Ssekitoleko; Shevin T Jacob; Patrick Banura; Relana Pinkerton; David B Meya; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; Rose Muhindo; Sanjay Bhagani; W Michael Scheld; Christopher C Moore Journal: Crit Care Med Date: 2011-10 Impact factor: 7.598
Authors: M Waiswa; B B Byarugaba; P Ocama; H Mayanja-Kizza; E Seremba; S Ganguli; M Crowther; R Colebunders Journal: Afr Health Sci Date: 2012-09 Impact factor: 0.927
Authors: Sérgio Monteiro de Almeida; Jennifer Marquie-Beck; Archana Bhatt; Scott Letendre; Allen McCutchan; Ron Ellis Journal: Arq Neuropsiquiatr Date: 2014-07 Impact factor: 1.420
Authors: Michael Hawkes; Andrea L Conroy; Robert O Opoka; Sophie Namasopo; W Conrad Liles; Chandy C John; Kevin C Kain Journal: Am J Trop Med Hyg Date: 2014-03-03 Impact factor: 2.345
Authors: Shevin T Jacob; Patrick Banura; Jared M Baeten; Christopher C Moore; David Meya; Lydia Nakiyingi; Rebecca Burke; Cheryl Lynn Horton; Boaz Iga; Anna Wald; Steven J Reynolds; Harriet Mayanja-Kizza; W Michael Scheld Journal: Crit Care Med Date: 2012-07 Impact factor: 7.598
Authors: Shevin T Jacob; Christopher C Moore; Patrick Banura; Relana Pinkerton; David Meya; Pius Opendi; Steven J Reynolds; Nathan Kenya-Mugisha; Harriet Mayanja-Kizza; W Michael Scheld Journal: PLoS One Date: 2009-11-11 Impact factor: 3.240